ORGANIC
LETTERS
XXXX
Vol. XX, No. XX
000–000
Iridium-Catalyzed Hydrogen Transfer:
Synthesis of Substituted Benzofurans,
Benzothiophenes, and Indoles from
Benzyl Alcohols
Bruno Anxionnat,† Domingo Gomez Pardo,† Gino Ricci,‡ Kai Rossen,§ and
Janine Cossy*,†
Laboratoire de Chimie Organique, ESPCI ParisTech, CNRS, 10 rue Vauquelin,
ꢀ
75231 Paris Cedex 05, France, Sanofi, Process Development, 45 chemin de Meteline,
BP 15, 04201 Sisteron Cedex, France, Sanofi-Aventis Deutschland GmbH, Chemistry &
€
Biotechnology Development (C&BD) Frankfurt Chemistry Industriepark Hoechst,
Building G 838, 65926 Frankfurt am Main, Germany
Received June 7, 2013
ABSTRACT
An iridium-catalyzed hydrogen transfer has been developed in the presence of p-benzoquinone, allowing the synthesis of a diversity of
substituted benzofurans, benzothiophenes, and indoles from substituted benzylic alcohols.
Oxidation is one of the most important reactions, and
oxidation state adjustments are very frequent operations in
organic synthesis. In green chemistry processes, heavy
metal oxidants in stoichiometric quantities have to be
avoided, and methods using nontoxic and recyclable
reagents need to be developed. Transition metal catalysts
such as palladium, copper, and ruthenium catalysts have
been utilized to oxidize alcohols in the presence of H2O2
and O2,1 and oxidation/reduction sequences using hydro-
gen transfer induced by iridium, cobalt, and rhodium
catalysts have been developed in the past 20 years.2 Iridium
complexes are more stable than rhodium and cobalt com-
plexes under thermal conditions; therefore iridium cata-
lysts are the catalysts of choice for hydrogen transfer
processes.3 Recently, we have reported that acetonitrile
could be monoalkylated by primary alcohols through a
one-pot oxidation/reduction sequence in the presence of
iridium catalysts4 and that intramolecular alkylation of
nitriles by primary and secondary alcohols via a hydrogen
transfer using [Ir(cod)Cl]2 or [IrCp*Cl2]2 catalysts led to
tetrahydronaphthalenes, chromanes, and thiochromanes
† ESPCI ParisTech, CNRS.
‡ Sanofi.
§ Sanofi-Aventis Deutschland GmbH.
(1) (a) Sheldon, R. A.; Arends, I. W. C. E.; Brink, G.-J.; Dijksman, A.
€
Acc. Chem. Res. 2002, 35, 774–781. (b) Piera, J.; Backvall, J.-E. Angew.
Chem., Int. Ed. 2008, 47, 3506–3523 and references therein.
(2) Tejel, C.; Ciriano, M. A. In Topics in Organometallic Chemistry,
Vol. 22; Springer-Verlag: Berlin, Heidelberg, 2007; pp 97À124 and
references therein.
(3) (a) Suzuki, T. Chem. Rev. 2011, 111, 1825–1845 and references
therein. (b) Sawaguchi, T.; Obora, Y. Chem. Lett. 2011, 40, 1055–1057. (c)
Zhou, J.; Fang, J. J. Org. Chem. 2011, 76, 7730–7736. (d) Zhang, W.; Dong,
X.; Zhao, W. Org. Lett. 2011, 13, 5386–5389. (e) Xu, C.; Goh, L. Y.;
Sumod, A. Organometallics 2011, 30, 6499–6502. (f) Maenaka, Y.; Suenobu,
T.; Fukuzumi, S. J. Am. Chem. Soc. 2011, 134, 367–374. (g) Li, F.; Shan, H.;
Chen, L.; Kang, Q.; Zou, P. Chem. Commun. 2012, 48, 603–605. (h) Xu, C.;
Dong, X.-M.; Wang, Z.-Q.; Hao, X.-Q.; Li, Z.; Duan, L.-M.; Ji, B.-M.;
Song, M.-P. J. Organomet. Chem. 2012, 700, 214–218. (i) Kawahara, R.;
Fujita, K.-I.; Yamaguchi, R. J. Am. Chem. Soc. 2012, 134, 3646–3646. (j)
Fang, J.; Zhou, J. Org. Biomol. Chem. 2012, 10, 2389–2391. (k) Michlik, S.;
Hille, T.; Kempe, R. Adv. Synth. Catal. 2012, 354, 847–862. (l) Feng, L.;
Kang, Q.; Shan, H.; Chen, L.; Xie, J. Eur. J. Org. Chem. 2012, 5085–5092.
(m) Li, J.; Zhang, W.; Wang, F.; Jiang, M.; Dong, X.; Zhao, W. Chin. J.
Chem. 2012, 30, 2363–2366. (n) Wetzel, A.; Woeckel, S.; Schelwies, M.;
Brinks, M. K.; Rominger, F.; Hofmann, P.; Limbach, M. Org. Lett. 2013,
15, 266–269. (o) Pan, S.; Shibata, T. ACS Catal. 2013, 3, 704–712.
(4) Anxionnat, B.; Gomez Pardo, D.; Ricci, G.; Cossy, J. Org. Lett.
2011, 13, 4084–4087.
r
10.1021/ol401610e
XXXX American Chemical Society